Damora Therapeutics, Inc. (DMRA)

Damora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	257.62	14.18	21.47	32.79	62.56
Short-Term Investments	-	-	11.69	27.44	37.63
Cash & Short-Term Investments	257.62	14.18	33.15	60.22	100.19
Cash Growth	1717.45%	-57.24%	-44.95%	-39.89%	-38.75%
Other Current Assets	2.8	2.66	3.62	3.69	9.91
Total Current Assets	260.42	16.84	36.77	63.91	110.1
Net Property, Plant & Equipment	0.1	0.13	0.33	1.17	1.04
Long-Term Investments	-	-	-	5.83	9.05
Other Long-Term Assets	-	0.16	1.13	2.28	2.03
Total Assets	260.53	17.13	38.23	73.19	122.22
Accounts Payable	17.67	0.38	1.7	3.35	1.53
Accrued Expenses	2.4	0.82	4.13	7.76	3.01
Total Current Liabilities	20.07	1.2	5.83	11.11	4.54
Long-Term Leases	0.05	0.06	0.07	0.33	0.45
Other Long-Term Liabilities	0.03	0.04	-	-	-
Total Long-Term Liabilities	0.08	0.1	0.07	0.33	0.45
Total Liabilities	20.15	1.3	5.9	11.44	4.99
Preferred Stock	416.25	1.36	-	-	-
Additional Paid-in Capital	310.69	291.9	288.04	279.73	273.66
Accumulated Other Comprehensive Income	0.8	0.1	0.38	-0.24	-0.32
Retained Earnings	-487.36	-277.52	-256.09	-217.74	-156.11
Shareholders' Equity	240.38	15.83	32.33	61.75	117.22
Total Liabilities & Equity	260.53	17.13	38.23	73.19	122.22
Total Debt	0.05	0.06	0.07	0.33	0.45
Net Cash (Debt)	257.57	14.11	33.09	59.9	99.74
Net Cash Growth	1724.93%	-57.34%	-44.76%	-39.95%	-38.82%
Net Cash Per Share	188.97	12.20	31.13	58.93	98.71
Book Value	240.38	15.83	32.33	61.75	117.22
Book Value Per Share	176.36	13.68	30.42	60.76	116.01
Tangible Book Value	240.38	15.83	32.33	61.75	117.22
Tangible Book Value Per Share	176.36	13.68	30.42	60.76	116.01

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q